A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients

被引:258
作者
Adragao, T [1 ]
Pires, A [1 ]
Lucas, C [1 ]
Birne, R [1 ]
Magalhaes, L [1 ]
Gonçalves, M [1 ]
Negrao, AP [1 ]
机构
[1] Nefroclin Estoril, P-2765293 Esteril, Portugal
关键词
haemodialysis; mortality; vascular calcification; vascular disease;
D O I
10.1093/ndt/gfh217
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Cardiovascular morbidity and mortality are highly prevalent in haemodialysis (HD) patients and have been recently associated with vascular calcifications. The objective of our study was to assess the value of a simple vascular calcification score for the prediction of cardiovascular death, cardiovascular hospitalizations and fatal and non-fatal cardiovascular events in HD patients, and to correlate this score with cardiovascular disease and with other known predictors of vascular disease. Methods. In this observational, prospective study 123 chronic HD patients (75 males and 48 females; 20% diabetic) were included, who were on low-flux HD treatment for 46.6 +/- 52 months (mean +/- SD). We set up a simple vascular calcification score based on plain radiographic films of pelvis and hands. Brachial pulse pressure and mean arterial pressure (MAP) were measured and cardiovascular events and hospitalization episodes were assessed. Results. During an observational period of 37 months there were 17 cardiovascular deaths; 28 patients needed cardiovascular hospitalizations and 32 patients suffered fatal and non-fatal cardiovascular events. Coronary artery disease was diagnosed in 43 patients (35%), peripheral arterial disease in 33 patients (26.8%), cerebrovascular disease in 16 patients (13%) and vascular disease (coronary artery disease or peripheral arterial disease or cerebral vascular disease) in 61 patients (49.6%). By binary logistic regression, diabetes (P=0.01), male sex (P<0.001), age (P=0.02), HD duration (P=0.02) and MAP (P=0.03) were independently associated with a vascular score >3. This score >3 was independently associated with coronary artery disease (P=0.008), peripheral arterial disease (P<0.001) and vascular disease (P=0.001). Patients with a vascular calcification score >3 had a 3.9-fold higher risk of cardiovascular mortality (P=0.03), a 2.8-fold higher risk of cardiovascular hospitalizations (P=0.02) and a 2.3-fold higher risk of fatal or non-fatal cardiovascular events (P=0.04). Conclusions. The present vascular calcification scoring represents a simple tool for the assessment of cardiovascular risk related with vascular calcifications in chronic HD patients.
引用
收藏
页码:1480 / 1488
页数:9
相关论文
共 25 条
[1]  
ADRAGAO T, 2003, NEPHROL DIAL TRAN S4, V18, P702
[2]   Helical and single-slice conventional CT versus electron beam CT for the quantification of coronary artery calcification [J].
Becker, CR ;
Jakobs, TF ;
Aydemir, S ;
Becker, A ;
Knez, A ;
Schoepf, UJ ;
Bruening, R ;
Haberl, R ;
Reiser, MF .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (02) :543-547
[3]   Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[4]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[5]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[6]   Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients [J].
Braun, J ;
Oldendorf, M ;
Moshage, W ;
Heidler, R ;
Zeitler, E ;
Luft, FC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :394-401
[7]   The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients [J].
Chertow, GM ;
Raggi, P ;
McCarthy, JT ;
Schulman, G ;
Silberzweig, J ;
Kuhlik, A ;
Goodman, WG ;
Boulay, A ;
Burke, SK ;
Toto, RD .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (05) :307-314
[8]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[9]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[10]   Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study [J].
Franklin, SS ;
Khan, SA ;
Wong, ND ;
Larson, MG ;
Levy, D .
CIRCULATION, 1999, 100 (04) :354-360